STAT+: For a leukemia that keeps returning, AbbVie drug may offer chance for a deep remission
STAT
DECEMBER 13, 2024
These compounds are double-armed antibodies that can grab onto cancer cells on one end and T cells with the other end. By doing so, the drug helps to guide immune cells to cancer cells and trigger the immune system to destroy the cancer. Epkinly is a type of drug called a bispecific T cell engager.
Let's personalize your content